CBS 2019
CBSMD教育中心
English

推荐文献

科研文章

荐读文献

Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events in the ODYSSEY OUTCOMES Trial Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting: insights from the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial at the 5-year follow-up Limitations of Repeat Revascularization as an Outcome Measure Healthy Behavior, Risk Factor Control, and Survival in the COURAGE Trial Significantly less inappropriate shocks in ischemic patients compared to non-ischemic patients: The S-ICD experience of a high volume single-center Potential protective mechanisms of green tea polyphenol EGCG against COVID-19 Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials Poor R-wave progression as a predictor of sudden cardiac death in general population and subjects with coronary artery disease Prognostic implication of lipidomics in patients with coronary total occlusion undergoing PCI Circadian Cadence and NR1D1 Tune Cardiovascular Disease
|<<... 18 19 20 21 22 23 24 25 >>|

GuidelineOctober 2017, Volume 10, Issue 10

JOURNAL：Circ Cardiovasc Qual Outcomes. Article Link

2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non–ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures

Jneid H, Addison D, Bhatt DL et al. Keywords: AHA Scientific Statements; ST-elevation myocardial infarction; acute myocardial infarction; non–ST-elevation myocardial infarction; performance measures; quality indicators; quality measures

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top